Spruce Biosciences (SPRB) traded down -1.85 % during a 24 hours period ending at 03:13 PM Central Europe on Monday 26th. One Spruce Biosciences stock can currently be bought for about USD 44.99 on popular exchanges. Current supply of Spruce Biosciences stocks is 2.9 mn. Spruce Biosciences has a current market capitalization of USD 129.8 mn and approximately USD 3.3 mn worth of Spruce Biosciences was traded on exchanges in the last 24 hours. Since last month end, Spruce Biosciences has traded -7.89 % down. Simple moving average of last 200 days is at USD 56.59. The highest price of past 52 weeks was recorded at USD 131.54 on 10/28/2025. 52 weeks low was at USD 38.06 on 10/14/2026.
Here is how related stocks have performed in the past 24 hours:
Sutro Biopharma (STRO) traded down -9.33 % and now trades at USD 8.84. Sutro Biopharma has a market capitalisation of USD 154.7 mn.
Vince (VNCE) traded down -1.89 % and now trades at USD 11.36. Current market capitalisation for Vince is USD 154.6 mn. Vince has a current price to earnings ratio of 20.4.
Red Robin Gourmet Burgers (RRGB) traded down -6.43 % and now trades at USD 8.25. Current market capitalisation for Red Robin Gourmet Burgers is USD 154.1 mn.
Graf Global (TONT) traded down -0.08 % and now trades at USD 10.94. Current market capitalisation for Graf Global is USD 154.9 mn.
Gowell Energy (GOW) traded up 0.3 % and now trades at USD 3.27. Gowell Energy has a market capitalisation of USD 154.7 mn.
About Spruce Biosciences
Spruce Biosciences, Inc. is a biotechnology company that specializes in endocrinology and orphan drug development to meet the unmet needs of patients suffering from endocrine disorders. The company operates in Daly City, United States, and serves patients nationwide. You can find more information about their activities and offerings on their website at www.sprucebiosciences.com . They are listed on the Nasdaq stock exchange.
